SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Sanara MedTech Inc. – ‘10-K’ for 12/31/23 – ‘EXCEL’

On:  Monday, 3/25/24, at 4:02pm ET   ·   For:  12/31/23   ·   Accession #:  1493152-24-11128   ·   File #:  1-39678

Previous ‘10-K’:  ‘10-K’ on 3/20/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   16 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/25/24  Sanara MedTech Inc.               10-K       12/31/23   83:7.8M                                   M2 Compliance LLC/FA

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.48M 
 2: EX-21.1     Subsidiaries List                                   HTML     25K 
 3: EX-23.1     Consent of Expert or Counsel                        HTML     21K 
 8: EX-97.1     Clawback Policy re: Recovery of Erroneously         HTML     41K 
                Awarded Compensation                                             
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     27K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     23K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     23K 
14: R1          Cover                                               HTML     95K 
15: R2          Consolidated Balance Sheets                         HTML    168K 
16: R3          Consolidated Balance Sheets (Parenthetical)         HTML     31K 
17: R4          Consolidated Statements of Operations               HTML    124K 
18: R5          Consolidated Statements of Changes in               HTML     84K 
                Shareholders' Equity                                             
19: R6          Consolidated Statements of Cash Flows               HTML    140K 
20: R7          Nature of Business and Background                   HTML     26K 
21: R8          Summary of Significant Accounting Policies          HTML    110K 
22: R9          Precision Healing Merger                            HTML     59K 
23: R10         Scendia Purchase Agreement                          HTML     48K 
24: R11         Applied Asset Purchase                              HTML     49K 
25: R12         Goodwill and Intangibles, Net                       HTML     53K 
26: R13         Investments in Equity Securities                    HTML     64K 
27: R14         Operating Leases                                    HTML     37K 
28: R15         Debt and Credit Facilities                          HTML     50K 
29: R16         Commitments and Contingencies                       HTML     80K 
30: R17         Shareholders? Equity                                HTML     95K 
31: R18         Customers and Suppliers                             HTML     28K 
32: R19         Income Taxes                                        HTML     61K 
33: R20         Related Parties                                     HTML     39K 
34: R21         Summary of Significant Accounting Policies          HTML    160K 
                (Policies)                                                       
35: R22         Summary of Significant Accounting Policies          HTML     63K 
                (Tables)                                                         
36: R23         Precision Healing Merger (Tables)                   HTML     48K 
37: R24         Scendia Purchase Agreement (Tables)                 HTML     42K 
38: R25         Applied Asset Purchase (Tables)                     HTML     41K 
39: R26         Goodwill and Intangibles, Net (Tables)              HTML     58K 
40: R27         Investments in Equity Securities (Tables)           HTML     46K 
41: R28         Operating Leases (Tables)                           HTML     31K 
42: R29         Debt and Credit Facilities (Tables)                 HTML     38K 
43: R30         Shareholders? Equity (Tables)                       HTML     66K 
44: R31         Income Taxes (Tables)                               HTML     54K 
45: R32         Schedule of Computation of Diluted Net Loss Per     HTML     32K 
                Share (Details)                                                  
46: R33         Schedule of Revenue From Product Sales and          HTML     33K 
                Royalties (Details)                                              
47: R34         Schedule of Property and Equipment (Details)        HTML     54K 
48: R35         Schedule of Changes in Fair Value for Contingent    HTML     33K 
                Earnout Consideration (Details)                                  
49: R36         Summary of Significant Accounting Policies          HTML     44K 
                (Details Narrative)                                              
50: R37         Schedule of Purchase Considerations (Details)       HTML     53K 
51: R38         Schedule of Purchase Consideration on Fair Value    HTML     63K 
                of Assets Acquired (Details)                                     
52: R39         Precision Healing Merger (Details Narrative)        HTML     70K 
53: R40         Scendia Purchase Agreement (Details Narrative)      HTML     53K 
54: R41         Schedule of Asset Purchase Considerations           HTML     41K 
                (Details)                                                        
55: R42         Applied Asset Purchase (Details Narrative)          HTML     37K 
56: R43         Schedule of Changes in the Carrying Amount of the   HTML     28K 
                Goodwill (Details)                                               
57: R44         Schedule of Finite Lived Intangible Assets          HTML     40K 
                (Details)                                                        
58: R45         Schedule of Future Amortization Expense (Details)   HTML     37K 
59: R46         Goodwill and Intangibles, Net (Details Narrative)   HTML     27K 
60: R47         Schedule of Investments (Details)                   HTML     34K 
61: R48         Schedule of Loss From Equity Method Investment      HTML     25K 
                (Details)                                                        
62: R49         Investments in Equity Securities (Details           HTML     71K 
                Narrative)                                                       
63: R50         Schedule of Operating Lease Liability (Details)     HTML     45K 
64: R51         Operating Leases (Details Narrative)                HTML     43K 
65: R52         Schedule of Long-Term Debt (Details)                HTML     39K 
66: R53         Schedule of Long-Term Debt (Details)                HTML     23K 
                (Parenthetical)                                                  
67: R54         Schedule of Maturities Outstanding Debt (Details)   HTML     41K 
68: R55         Debt and Credit Facilities (Details Narrative)      HTML     58K 
69: R56         Commitments and Contingencies (Details Narrative)   HTML    192K 
70: R57         Summary of Restricted Stock Activity (Details)      HTML     42K 
71: R58         Schedule of Stock Option Activity (Details)         HTML     56K 
72: R59         Schedule of Warrants to Purchase Common Stock       HTML     53K 
                (Details)                                                        
73: R60         Shareholders? Equity (Details Narrative)            HTML    144K 
74: R61         Customers and Suppliers (Details Narrative)         HTML     31K 
75: R62         Schedule of Deferred Tax Assets (Details)           HTML     59K 
76: R63         Schedule of Income Tax Expense (Benefit) (Details)  HTML     57K 
77: R64         Income Taxes (Details Narrative)                    HTML     34K 
78: R65         Related Parties (Details Narrative)                 HTML     37K 
80: XML         IDEA XML File -- Filing Summary                      XML    142K 
83: XML         XBRL Instance -- form10-k_htm                        XML   1.48M 
79: EXCEL       IDEA Workbook of Financial Report Info              XLSX    125K 
10: EX-101.CAL  XBRL Calculations -- smti-20231231_cal               XML    255K 
11: EX-101.DEF  XBRL Definitions -- smti-20231231_def                XML    665K 
12: EX-101.LAB  XBRL Labels -- smti-20231231_lab                     XML   1.29M 
13: EX-101.PRE  XBRL Presentations -- smti-20231231_pre              XML    998K 
 9: EX-101.SCH  XBRL Schema -- smti-20231231                         XSD    175K 
81: JSON        XBRL Instance as JSON Data -- MetaLinks              492±   675K 
82: ZIP         XBRL Zipped Folder -- 0001493152-24-011128-xbrl      Zip    306K 


‘EXCEL’   —   IDEA Workbook of Financial Report Info


This is an IDEA Workbook.

        Download this Microsoft® Excel® .xlsx workbook


16 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/22/24  Sanara MedTech Inc.               8-K:5,9     3/21/24   11:533K                                   M2 Compliance LLC/FA
 8/02/23  Sanara MedTech Inc.               8-K:1,2,3,7 8/01/23   14:1M                                     M2 Compliance LLC/FA
 3/20/23  Sanara MedTech Inc.               10-K       12/31/22   85:7.4M                                   M2 Compliance LLC/FA
 2/24/23  Sanara MedTech Inc.               8-K:1,9     2/24/23   13:655K                                   M2 Compliance LLC/FA
 7/05/22  Sanara MedTech Inc.               8-K:1,2,3,7 7/01/22   12:779K                                   M2 Compliance LLC/FA
 4/29/22  Sanara MedTech Inc.               8-K:5,9     4/28/22   12:678K                                   M2 Compliance LLC/FA
 4/08/22  Sanara MedTech Inc.               8-K:1,2,3,7 4/04/22   14:706K                                   M2 Compliance LLC/FA
 4/04/22  Sanara MedTech Inc.               8-K:1,3,7,9 4/01/22   12:1.4M                                   M2 Compliance LLC/FA
 7/19/21  Sanara MedTech Inc.               8-K:1,3,7,9 7/14/21    4:260K                                   Blueprint/FA
 3/30/21  Sanara MedTech Inc.               10-K       12/31/20   64:4.7M                                   Blueprint/FA
 2/01/21  Sanara MedTech Inc.               8-K:1,9     1/26/21    4:203K                                   Blueprint/FA
11/13/20  Sanara MedTech Inc.               10-Q        9/30/20   53:3.2M                                   Blueprint/FA
 5/12/20  Sanara MedTech Inc.               10-Q        3/31/20   49:6.3M                                   Blueprint/FA
11/14/19  Sanara MedTech Inc.               10-Q        9/30/19   48:7M                                     Blueprint/FA
 8/14/19  Sanara MedTech Inc.               10-Q        6/30/19   39:5.7M                                   Blueprint/FA
11/14/18  Sanara MedTech Inc.               10-Q        9/30/18   40:13M                                    Blueprint/FA
Top
Filing Submission 0001493152-24-011128   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 8, 12:15:37.1pm ET